Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07211568 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PERT in Acute Necrotizing Pancreatitis

Study acronym: PERT-ANP
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
In this multicenter, double blinded, placebo-controlled, 1:1 parallel group RCT, we propose to evaluate the impact of pancreatic exocrine replacement therapy on patients with acute necrotizing pancreatitis (ANP). We will include patients of 18-60yrs age and both genders with \>50% pancreatic parenchymal necrosis and \>10% loss of body weight. The primary outcome measure is change in BMI at 3 months after enrolment. The intervention will include pancreatic enzyme consisting of 25000 IU of lipase and similar appearing placebo.
Trial Details
NCT Number NCT07211568
Lead Sponsor Asian Institute of Gastroenterology, India
Conditions
(from sponsor)		 Acute Pancreatitis Necrotizing, Nutrition Assessment
Related terms Exocrine Pancreatic Insufficiency, Pancreatitis, Acute Necrotizing
Enrollment 188 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov